Can antiviral therapy for chronic hepatitis B enhance the progression to hepatocellular carcinoma?

被引:1
|
作者
Warner, Nadia [1 ]
Locarnini, Stephen [1 ]
机构
[1] Victorian Infect Dis Reference Labs, Melbourne, Vic, Australia
关键词
VIRUS-DNA; TRANSMEMBRANE TOPOLOGY; TRANSCRIPTIONAL TRANSACTIVATOR; LAMIVUDINE THERAPY; PRES/S-SEQUENCES; SURFACE-ANTIGEN; YMDD-MOTIF; INFECTION; REGION; GENOTYPE;
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:139 / 142
页数:4
相关论文
共 50 条
  • [31] Impact of antiviral therapy on risk prediction model for hepatocellular carcinoma development in patients with chronic hepatitis B
    Chon, Hye Yeon
    Lee, Jae Seung
    Lee, Hye Won
    Chun, Ho Soo
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Seung Up
    HEPATOLOGY RESEARCH, 2021, 51 (04) : 406 - 416
  • [32] Liver cirrhosis stages and the incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving antiviral therapy
    Shim, Jae-Jun
    Oh, Chi Hyuck
    Kim, Jung Wook
    Lee, Chang Kyun
    Kim, Byung-Ho
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (09) : 1029 - 1036
  • [33] Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B
    Tziomalos, Konstantinos
    WORLD JOURNAL OF HEPATOLOGY, 2010, 2 (03) : 91 - 93
  • [34] Hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment with virological suppression
    Ghaly, S.
    Bu, K.
    Yan, K.
    Choo, L.
    George, J.
    Chu, F.
    Strasser, S.
    Zekry, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 51 - 51
  • [36] Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy
    Lee, M.
    Kim, J. H.
    Jun, B. G.
    Kim, T. S.
    Cho, E. -H.
    Choi, D. H.
    Suk, K. T.
    Kang, S.
    Kim, M. Y.
    Kim, Y. D.
    Cheon, G. J.
    Kim, D. J.
    Baik, S. K.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S482 - S483
  • [37] Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy
    Kim, Ji Hyun
    Kim, Young Don
    Lee, Minjong
    Jun, Baek Gyu
    Kim, Tae Suk
    Suk, Ki Tae
    Kang, Seong Hee
    Kim, Moon Young
    Cheon, Gab Jin
    Kim, Dong Joon
    Baik, Soon Koo
    Choi, Dae Hee
    JOURNAL OF HEPATOLOGY, 2018, 69 (05) : 1066 - 1073
  • [38] Preventive effects of antiviral therapy on progression of chronic hepatitis C virus infection to liver cirrhosis and hepatocellular carcinoma in Taiwan
    Yu, ML
    Chuang, WL
    Dai, CY
    Lee, LP
    Chen, SC
    Lin, ZY
    Hsieh, MY
    Wang, LY
    Chang, WY
    JOURNAL OF HEPATOLOGY, 2003, 38 : 183 - 183
  • [39] Antiviral therapy for hepatitis B virus infection is beneficial for the prognosis hepatocellular carcinoma
    Wan, Hui
    Zhang, Yu-Xin
    Shan, Guan-Yue
    Cheng, Jun-Ya
    Qiao, Duan-Rui
    Liu, Yi-Ying
    Shi, Wen-Na
    Li, Hai-Jun
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 17 (01)
  • [40] Antiviral Therapy and Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence
    Yeh, Yi-Chun
    Chen, Pei-Jer
    Lai, Mei-Shu
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08): : 765 - 766